These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22933134)

  • 1. Limited use of nonprogram screening in Norway.
    Kalager M; Løberg M; Bretthauer M
    Int J Cancer; 2013 Apr; 132(7):1723-4. PubMed ID: 22933134
    [No Abstract]   [Full Text] [Related]  

  • 2. Mammography screening before introduction of the national breast screening programme in Norway.
    Autier P
    Int J Cancer; 2013 Apr; 132(7):1721-2. PubMed ID: 22933058
    [No Abstract]   [Full Text] [Related]  

  • 3. Thirteen years of breast screening had no measurable effect on breast cancer mortality in Norway.
    Jørgensen KJ; Brodersen J; Gøtzsche PC
    Int J Cancer; 2013 Apr; 132(7):1725-6. PubMed ID: 22933188
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast cancer mortality in Norway after the introduction of mammography screening.
    Olsen AH; Lynge E; Njor SH; Kumle M; Waaseth M; Braaten T; Lund E
    Int J Cancer; 2013 Jan; 132(1):208-14. PubMed ID: 22532175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Does organized mammographic screening reduce the breast cancer mortality?].
    Zahl PH; Strand BH
    Tidsskr Nor Laegeforen; 2002 Feb; 122(5):551; author reply 551. PubMed ID: 11961987
    [No Abstract]   [Full Text] [Related]  

  • 6. Constant relative survival rates in Sweden and Norway when adjusting for screening-related overdiagnosis.
    Zahl PH; Maehlen J
    Int J Cancer; 2007 May; 120(10):2279; author reply 2280. PubMed ID: 17230530
    [No Abstract]   [Full Text] [Related]  

  • 7. [Should mammography screening be adopted in Norway?].
    Reiertsen O; Reed W
    Tidsskr Nor Laegeforen; 1986 Jun; 106(19-21):1605-7. PubMed ID: 3764845
    [No Abstract]   [Full Text] [Related]  

  • 8. [Breast cancer mortality versus breast cancer survival].
    Zahl PH; Maehlen J
    Tidsskr Nor Laegeforen; 2010 Feb; 130(3):261. PubMed ID: 20160765
    [No Abstract]   [Full Text] [Related]  

  • 9. Author's reply: Breast cancer mortality in Norway after the introduction of mammography screening.
    Lynge E; Njor SH; Olsen AH; Waaseth M; Braaten T; Lund E; Kumle M
    Int J Cancer; 2013 Apr; 132(7):1727. PubMed ID: 22933244
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of screening mammography on breast-cancer mortality in Norway.
    Kalager M; Zelen M; Langmark F; Adami HO
    N Engl J Med; 2010 Sep; 363(13):1203-10. PubMed ID: 20860502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Breast cancer mortality in Norway and England].
    Tverdal A
    Tidsskr Nor Laegeforen; 2000 Sep; 120(22):2703. PubMed ID: 11077521
    [No Abstract]   [Full Text] [Related]  

  • 12. [Is the benefit of organized mass screening for cervix cancer and breast cancer in Norway scientifically justified?].
    Zahl PH
    Tidsskr Nor Laegeforen; 2000 Jun; 120(17):2002-5. PubMed ID: 11008534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mammography in Norway].
    Kåresen R; Thoresen SO
    Nord Med; 1995; 110(8-9):224-5. PubMed ID: 7478974
    [No Abstract]   [Full Text] [Related]  

  • 14. [Screening for cancer].
    Bjørge T; Tropé CG; Engeland A
    Tidsskr Nor Laegeforen; 1999 Mar; 119(8):1129-36. PubMed ID: 10228417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does organized mammographic screening reduce breast cancer mortality? The Cancer Registry's view on the current debate].
    Wang H; Hofvind S; Tretli S; Thoresen S; Langmark F
    Tidsskr Nor Laegeforen; 2002 Jan; 122(2):211-3. PubMed ID: 11873583
    [No Abstract]   [Full Text] [Related]  

  • 16. Comments on Survival of breast cancer patients in Lithuania and Norway, 1988-1992, Kliukiene and Andersen, Eur J Cancer 1998, 34, pp. 372-377.
    de Souza RM
    Eur J Cancer; 1998 Oct; 34(11):1812-3. PubMed ID: 9893674
    [No Abstract]   [Full Text] [Related]  

  • 17. [Occurrence and mortality of breast cancer in Norway. Can early diagnosis explain the different trends?].
    Lund E
    Tidsskr Nor Laegeforen; 1989 Apr; 109(10):1073-5. PubMed ID: 2786267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammography activity in Norway 1983 to 2008.
    Lynge E; Braaten T; Njor SH; Olsen AH; Kumle M; Waaseth M; Lund E
    Acta Oncol; 2011 Oct; 50(7):1062-7. PubMed ID: 21830995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage-specific incidence and survival of breast cancer in Norway: The implications of changes in coding and classification practice.
    Larsen IK; Myklebust TÅ; Johannesen TB; Møller B; Hofvind S
    Breast; 2018 Apr; 38():107-113. PubMed ID: 29306771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organised mammographic screening--more benefits than harms.
    Hofvind S
    Tidsskr Nor Laegeforen; 2013 Mar; 133(6):619-20. PubMed ID: 23552154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.